You just read:

RegeneRx Receives Notice of Acceptance for Patent in Australia For Treatment of Neural Injury with Thymosin Beta 4.

News provided by

RegeneRx Biopharmaceuticals, Inc.

Jan 09, 2017, 08:30 ET